A reduced sPD-L1 in the circulation is compatible with reports suggesting that HNSCC often localizes PD-L1 expression to the TME, thereby concentrating immunosuppressive signaling to the tumor-immune interface rather than to a systemic phenomenon (6, 44). Here, SPDL1 is linked to neoplasm.